Meet the 2022 Chief Financial Officer of the Year: Cingulate’s Louis G. Van Horn, as Recognized by the Kansas City Business Journal
Kansas City Business Veteran, Two-Time Award Winner, Helped Lead Cingulate to 2021 IPO KANSAS CITY, Kan., July 25, 2022 (GLOBE NEWSWIRE) — Cingulate Inc. (NASDAQ: CING), a clinical-stage biopharmaceutical company utilizing its proprietary Precision Timed Release™ (PTR™) drug delivery platform technology to build and advance a pipeline of next-generation pharmaceutical products, today announced that Chief…